Literature DB >> 31037426

Fibrous Dysplasia of Bone and McCune-Albright Syndrome: A Bench to Bedside Review.

Iris Hartley1,2, Maria Zhadina1,3, Micheal T Collins1, Alison M Boyce4.   

Abstract

Fibrous dysplasia is an uncommon mosaic disorder in which bone is replaced by structurally unsound fibro-osseous tissue. It is caused by the sporadic post-zygotic activating mutations in GNAS, resulting in dysregulated GαS-protein signaling in affected tissues. This manifests on a broad clinical spectrum ranging from insignificant solitary lesions to severe disease with deformities, fractures, functional impairment, and pain. Fibrous dysplasia may present in isolation or in association with hyperfunctioning endocrinopathies and café-au-lait macules, known as McCune-Albright Syndrome. This review summarizes the current understanding of pathophysiology in fibrous dysplasia, describes key pre-clinical and clinical investigations, and details the current approach to diagnosis and management.

Entities:  

Keywords:  Bone disorders; Bone metabolism; FGF23-mediated hypophosphatemia; McCune–Albright syndrome

Mesh:

Substances:

Year:  2019        PMID: 31037426      PMCID: PMC6541017          DOI: 10.1007/s00223-019-00550-z

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  87 in total

1.  A sensitive mutation-specific screening technique for GNAS1 mutations in cases of fibrous dysplasia: the first report of a codon 227 mutation in bone.

Authors:  B D Idowu; M Al-Adnani; P O'Donnell; L Yu; E Odell; T Diss; R E Gale; A M Flanagan
Journal:  Histopathology       Date:  2007-05       Impact factor: 5.087

2.  GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours.

Authors:  C A Landis; S B Masters; A Spada; A M Pace; H R Bourne; L Vallar
Journal:  Nature       Date:  1989-08-31       Impact factor: 49.962

Review 3.  Prevalence of Different Forms and Involved Bones of Craniofacial Fibrous Dysplasia.

Authors:  Liya Yang; Huanhuan Wu; Jianjian Lu; Li Teng
Journal:  J Craniofac Surg       Date:  2017-01       Impact factor: 1.046

Review 4.  Fibro-osseous lesions of the craniofacial skeleton: an update.

Authors:  Samir K El-Mofty
Journal:  Head Neck Pathol       Date:  2014-11-20

5.  The Will Rogers phenomenon: improved technologic diagnosis and stage migration as a source of nontherapeutic improvement in cancer prognosis.

Authors:  A R Feinstein; D A Sosin; C K Wells
Journal:  Trans Assoc Am Physicians       Date:  1984

6.  Synthesis in Escherichia coli of GTPase-deficient mutants of Gs alpha.

Authors:  M P Graziano; A G Gilman
Journal:  J Biol Chem       Date:  1989-09-15       Impact factor: 5.157

7.  Activating mutations of the stimulatory G protein in the McCune-Albright syndrome.

Authors:  L S Weinstein; A Shenker; P V Gejman; M J Merino; E Friedman; A M Spiegel
Journal:  N Engl J Med       Date:  1991-12-12       Impact factor: 91.245

8.  Activating Gsalpha mutations: analysis of 113 patients with signs of McCune-Albright syndrome--a European Collaborative Study.

Authors:  Serge Lumbroso; Françoise Paris; Charles Sultan
Journal:  J Clin Endocrinol Metab       Date:  2004-05       Impact factor: 5.958

9.  Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone.

Authors:  P Bianco; M Riminucci; A Majolagbe; S A Kuznetsov; M T Collins; M H Mankani; A Corsi; H G Bone; S Wientroub; A M Spiegel; L W Fisher; P G Robey
Journal:  J Bone Miner Res       Date:  2000-01       Impact factor: 6.741

10.  GNAS transcripts in skeletal progenitors: evidence for random asymmetric allelic expression of Gs alpha.

Authors:  Stefano Michienzi; Natasha Cherman; Kenn Holmbeck; Alessia Funari; Michael T Collins; Paolo Bianco; Pamela Gehron Robey; Mara Riminucci
Journal:  Hum Mol Genet       Date:  2007-06-12       Impact factor: 6.150

View more
  8 in total

Review 1.  Congenital Conditions of Hypophosphatemia in Children.

Authors:  Erik Allen Imel
Journal:  Calcif Tissue Int       Date:  2020-04-23       Impact factor: 4.333

2.  Regression of fibrous dysplasia in response to denosumab therapy: A report of two cases.

Authors:  Maartje E Meier; Wouter van der Bruggen; Michiel A J van de Sande; Natasha M Appelman-Dijkstra
Journal:  Bone Rep       Date:  2021-04-09

3.  Case Report: A Neuro-Ophthalmological Assessment of Vision Loss in a Pediatric Case of McCune-Albright Syndrome.

Authors:  Jordan D Lemme; Anthony Tucker-Bartley; Laura A Drubach; Nehal Shah; Laura Romo; Mariesa Cay; Stephan Voss; Neha Kwatra; Leonard B Kaban; Adam S Hassan; Alison M Boyce; Jaymin Upadhyay
Journal:  Front Med (Lausanne)       Date:  2022-03-15

Review 4.  Genetics and Epigenetics of Bone Remodeling and Metabolic Bone Diseases.

Authors:  Lucia Oton-Gonzalez; Chiara Mazziotta; Maria Rosa Iaquinta; Elisa Mazzoni; Riccardo Nocini; Lorenzo Trevisiol; Antonio D'Agostino; Mauro Tognon; John Charles Rotondo; Fernanda Martini
Journal:  Int J Mol Sci       Date:  2022-01-28       Impact factor: 5.923

5.  Pathological Femoral Shaft Fracture With McCune-Albright Syndrome With Hyperthyroidism Managed With Oral Alendronate: A Case Report.

Authors:  Kuldeep Bansal; Avijeet Prasad; Sumedha Singh; Ankita Chauhan; Shubham Singla
Journal:  Cureus       Date:  2022-07-13

6.  Injectable demineralized bone matrix particles and their hydrogel bone grafts loaded with β-tricalcium phosphate powder and granules: A comparative study.

Authors:  Hoe-Jin Kang; Seong-Su Park; Garima Tripathi; Byong-Taek Lee
Journal:  Mater Today Bio       Date:  2022-09-09

7.  Kyphotic deformity of the lumbar spine due to a monostotic fibrous dysplasia of the second lumbar vertebra: a case report and its surgical management.

Authors:  Anna Stocsits; Sara Lener; Pierre Pascal Girod; Anto Abramovič; Claudius Thomé; Sebastian Hartmann
Journal:  Acta Neurochir (Wien)       Date:  2020-08-17       Impact factor: 2.216

Review 8.  Fibrous Dysplasia/McCune-Albright Syndrome: A Rare, Mosaic Disease of Gα s Activation.

Authors:  Alison M Boyce; Michael T Collins
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.